| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 06/21/2006 | EP1438316B1 Phosphonic acid compounds as inhibitors of serine proteases |
| 06/21/2006 | EP1401415B1 Use of n-phenyl-2-pyrimidine-amine derivatives for treating inflammatory diseases |
| 06/21/2006 | EP1366049B1 Pirazino¬1'2':1,6|pyrido¬3,4-b|indole derivatives |
| 06/21/2006 | EP1309322B1 Use of 3-benzoylphenylacetic acid derivatives for the treatment of retinal disorders |
| 06/21/2006 | EP1282599B1 Disulfide derivatives useful for treating allergic diseases |
| 06/21/2006 | EP1255734B1 Isatine derivatives with neurotrophic activity |
| 06/21/2006 | EP1244647B1 Quinazoline derivatives as vegf inhibitors |
| 06/21/2006 | EP1208092B1 Sulfonamide derivative as a matrix metalloproteinase inhibitor |
| 06/21/2006 | EP1200094B1 Ophthalmic compositions containing antibiotics and nsaids |
| 06/21/2006 | EP1140170B1 Antibody fragments for the topical treatment of ocular diseases |
| 06/21/2006 | EP1025106B1 Allosteric adenosine receptor modulators |
| 06/21/2006 | CN1791383A Self-emulsifying compositions, methods of use and preparation |
| 06/21/2006 | CN1789246A Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
| 06/21/2006 | CN1788790A Extrasin beta-16 for promoting vascularization, tissue regeneration and wound healing |
| 06/21/2006 | CN1788776A Chinese traditional medicine for treating diabetes retinopathy |
| 06/21/2006 | CN1788609A Preparation method of gastrodia tuber essence serial health product |
| 06/21/2006 | CN1260227C 5-membered ring heterocyclic compounds with nitrogen |
| 06/21/2006 | CN1260226C Tetrahydro-(benzo or thieno)-azepine-pyrazine and triazine derivatives as mGluR1 antagonists |
| 06/21/2006 | CN1259952C External used ointment of Chinese medicine for acute or chronic tympanitis |
| 06/21/2006 | CN1259901C Musk liposome injection and its preparation method |
| 06/20/2006 | US7064236 such as dimethyl-[phenyl-(2-phenyl-cyclohex-1-enyl)-methyl]-amine for treatment of pain, depression, hypotension, senile dementia, tinnitus, hearing loss, epilepsy, obesity, cachexia, urinary incontinence, anxiolysis, diuresis, and alzheimer's disease |
| 06/20/2006 | US7064204 Nitrogen compounds such as 4-(5-amino-7-phenethyl-7H-pyrazolo (4,3-e)(1,2,4)triazolo(1,5-c)pyrimidin-2-yl)-phenol, used as adenosine receptor antagonists, for prophylaxis of nervous, cardiovascular, respiratory, urogenital and immune disorders |
| 06/20/2006 | US7064147 Amino acids with affinity for the α-2-delta-protein |
| 06/20/2006 | US7064141 Method for preventing, treating or inhibiting development of simple retinopathy and preproliferative retinopathy |
| 06/20/2006 | US7064109 Pharmaceutical composition based on macrolides for topical application in ophthalmology |
| 06/20/2006 | CA2121523C Sulfonamide derivatives |
| 06/15/2006 | WO2006063179A1 12-aryl prostaglandin analogs |
| 06/15/2006 | WO2006062839A1 Use of dioxindoindazoles and dioxoloindazoles for treating glaucoma |
| 06/15/2006 | WO2006062731A1 Phenanthroline and derivatives thereof used to lower intraocular pressure in an affected eye |
| 06/15/2006 | WO2006062184A1 Product containing prostaglandin having fluorine atom in molecule |
| 06/15/2006 | WO2006061596A1 Linseed eye compresses |
| 06/15/2006 | WO2006061525A2 Compositions for treating surface ocular pathologies |
| 06/15/2006 | WO2006061156A2 Medicament for hygienic application inside the ear |
| 06/15/2006 | WO2006061155A2 Stabilisation of glucocorticoid esters with acids |
| 06/15/2006 | US20060128810 Remedies for allergic diseases |
| 06/15/2006 | US20060128780 Cyclic substituted fused pyrrolocarbazoles and isoindolones |
| 06/15/2006 | US20060128776 Opioid receptor active compounds |
| 06/15/2006 | US20060128772 2-(2-methoxyphenyl)-3-(2-methoxy-phenyl)-5-phenylamino-(1,2,4)-thiadiazol-2 -ium; metabolic, nervous system and dermatological disorders, antidiabetic; obesity, impaired oral glucose tolerance, type II diabetes and Syndrome X, acne, dry skin and seborrheic dermatitis |
| 06/15/2006 | US20060128770 Thiazole derivatives |
| 06/15/2006 | US20060128639 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 06/15/2006 | US20060128638 Treating atheroma, tumors and other neoplastic tissue; treating atherosclerotic inflammation; forming a complexes with a reducing agent, penetrate and accumulate more rapidly in tumor cells, plaque, increase drug in intracellular concentration; increase photosensitivity |
| 06/15/2006 | US20060128629 Angiogenesis inhibitors, antitumor agents |
| 06/15/2006 | US20060128619 Therapeutic use of modulators of notch |
| 06/15/2006 | US20060127481 Ophthalmic drug delivery system using polymer micell |
| 06/15/2006 | US20060127445 Anti-angiogenic compositions and methods of use |
| 06/15/2006 | US20060127411 Immune -modulating peptide made of s.aureus enterotoxin b |
| 06/15/2006 | CA2594103A1 Medicament for hygienic application inside the ear |
| 06/15/2006 | CA2591296A1 Stabilisation of glucocorticoid esters with acids |
| 06/15/2006 | CA2590277A1 Product containing prostaglandin having fluorine atom in its molecule |
| 06/15/2006 | CA2589864A1 12-aryl prostaglandin analogs |
| 06/14/2006 | EP1669078A1 Cerebrovascular regeneration/reconstruction promoters and nerve tissue secondary degeneration inhibitors comprising ginsenoside RB 1 |
| 06/14/2006 | EP1669075A1 Therapeutic agent for ageing macular degeneration |
| 06/14/2006 | EP1667721A2 Combinations of a vegf receptor inhibitor with other therapeutic agents |
| 06/14/2006 | EP1667693A1 Compositions and methods of using lamellar bodies for therapeutic purposes |
| 06/14/2006 | EP1497292B1 Azaindolylpiperidine derivatives as antihistaminic and antiallergic agents |
| 06/14/2006 | EP1399439B1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases |
| 06/14/2006 | EP1393075A4 Methods of screening and using inhibitors of angiogenesis |
| 06/14/2006 | EP1341770B1 Substituted 2-anilino-benzimidazoles and the use thereof as nhe-inhibitors |
| 06/14/2006 | EP1268418B1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors |
| 06/14/2006 | EP1165085B1 Phthalazine derivatives for treating inflammatory diseases |
| 06/14/2006 | EP1135115B1 Use of sibutramine for the treatment of disorders of the central nervous system secondary to organic impairments |
| 06/14/2006 | EP0750509B2 USE OF IL-12 AND IL-12 ANTAGONISTS for the manufacture of a pharmaceutical composition for THE TREATMENT OF AUTOIMMUNE DISEASES |
| 06/14/2006 | DE102005055385A1 Arzneimittel zur hygienischen Applikation im Ohr Medicines for hygienic application in the ear |
| 06/14/2006 | CN1785431A Adjuvant of slow release agent used for eye and medicine containing said adjurant and its preparation method |
| 06/14/2006 | CN1785356A Oral medicine for treating trachoma |
| 06/14/2006 | CN1785343A Ready prepared Chinese medicine for treating epicophosis and sonitus |
| 06/14/2006 | CN1785327A Medicine for trenting tympanitis |
| 06/14/2006 | CN1785301A Ready prepared chinese medicine 'erjingling' drops for treating tympanitis and its preparation method |
| 06/14/2006 | CN1785192A Eye-drops prepns. contg. tetrandrine and its application for preparing medicine therewith |
| 06/14/2006 | CN1785053A Health-care food for relieving-vision fatigue and its prepn. method |
| 06/14/2006 | CN1259316C Heterocyclic compounds for aging-related and diabetic vascular complications |
| 06/14/2006 | CN1259094C Chinese medicine for treating otitis media and its preparation |
| 06/14/2006 | CN1259081C Oral liquid for treating ophthalmic diseases |
| 06/14/2006 | CN1259080C Bacteria and virus resisting and inflammation eliminating eye drop and its preparing process |
| 06/14/2006 | CN1259051C Medicines and medicinal kits |
| 06/14/2006 | CN1259049C Composition for topical administration comprising an interleukin-2 inhibitor and an antimicrobial agent |
| 06/14/2006 | CN1259042C Calcium phenol sulfonate dispersive tablets and their preparation |
| 06/13/2006 | US7060836 Lactams as tachykinin antagonists |
| 06/13/2006 | US7060827 Intermediates useful for making 2,4-pyrimidinediamine compounds |
| 06/13/2006 | US7060824 Pyrrolotriazolopyrimidinone derivatives |
| 06/13/2006 | US7060716 Compound containing two triple bonds |
| 06/13/2006 | US7060699 Aryl and heteroaryl diazabicycloalkanes, their preparation and use |
| 06/13/2006 | US7060683 for treatment of neurodegeneration, stroke, Alzheimer's, amyotrophy, motor neuron damage, acute central nervous system injury, muscular dystrophy, bone resorption, platelet aggregation, cataracts and inflammation |
| 06/13/2006 | US7060681 Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids |
| 06/13/2006 | US7060269 Anti-VEGF antibodies |
| 06/13/2006 | CA2180008C Cyclopentane(ene) heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents |
| 06/08/2006 | WO2006060618A2 Topical nepafenac formulations |
| 06/08/2006 | WO2006059801A1 7-membered ring compound, process for producing the same, and medicinal use thereof |
| 06/08/2006 | WO2006059357A2 Use of compounds that interfere with the hedgehog signaling pathway for the manufacture of a medicament for preventing, inhibiting, and/ or reversing ocular diseases related with ocular neovascularization |
| 06/08/2006 | WO2006058592A1 Novel specific caspase-10 inhibitors |
| 06/08/2006 | WO2006021817A3 Treatment of eye disorders characterized by an elevated introacular pressure by sirnas |
| 06/08/2006 | WO2006017347B1 Opthalmic compositions and methods for treating ophthalmic conditions |
| 06/08/2006 | WO2005117968A3 Compositions and methods comprising an egfl7 antagonist for modulating vascular development |
| 06/08/2006 | US20060122392 Tri-heterocyclic compounds and a pharmaceutical comprising them as an active ingredient |
| 06/08/2006 | US20060122374 Albumin-fused anti-angiogenesis peptides |
| 06/08/2006 | US20060122280 Muscarinic agonists |
| 06/08/2006 | US20060122264 Stem cell invasion inhibitor |
| 06/08/2006 | US20060122249 Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
| 06/08/2006 | US20060122244 Hypoglycemic agents; antidiabetic agentys; side effect reduction; cardiovascular disorders; anticancer agents |
| 06/08/2006 | US20060122234 Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors |